perwnt.ol~stonas-conta~n%tmyite (magnesium ammonium phosphate) produced by a urinary tract infection with bacteri; that express the enzyme urease? F~e~p e r~e~-~f +~t~~~~~~~~~~~i~~c --. a 1 :~ 4 e-nt 'P contain-more~-rhan~QQ~c~ccnt-hydroxy-apatl or calcium monoh.y-drogen phosphate (brushite), and less than d-pe~~&e..%emp&gfTs~&e. Whereas most calcium oxalate s t 0 5 are less than 2 cm in diameter. struvite, uric acid, and cystine stones may fill the renal collecting system (staghorn calculi). Tiny flecks of calcium salts that encrust calyces can make kidney radiographs seem like pictures of the night sky (nephrocalcinosis). Calcium oxalate, uric acid, or cystine crystallites can scour the urinary tract, cause pain and bleeding, and then disperse -a process commonly described as "passing gravel" and more formally termed "crystalluria."
The-composition of every stone should be analyzed. Polarization microscopy4 is an inexpensive guide to differentiation; infrared and x-ray diffraction techniques surpass microscopy in precision and sensitivity: but we have not found their use essential. Galoiurn exalate and-calcium phosphate stones are black, gray, or white; on x-ray films they are small (< 1 cm in diameter), dense, opaque, and sharply circumscribed. Uaic.aeid stones are white or orange, and uric acid gravel is orange but nearly transparent radiograph;-cally-unless mixed with calcium crystah or struvite. Uric acid stones are typically seen as filling defects on intravenous pyelograms. C T scanning can distinguish them from kidney tissue or blood clots and reveal their sizes and shapes6 Struvite stones seem gnarled and laminated on radiographs; they look like ginger root. Cystine stones are greenish yellow and flecked with shiny crystallites, like mica. On x-ray films, they look like homogeneous pieces of sculpted wax or soap. Urinalysis can reveal the presence of crystals and provide clues to the type of stone; some of the common types are shown in Figure 1 .
Think about a beaker of water with calcium oxalate crystals in it; the concentration of calcium oxalate salt in the water is just high enough to prevent the crystals from dissolving and not high enough to allow them to grow. That exact concentration is the solubility of calcium oxalate; concentrations above it are called supersaturated, below it undersaturated. I n normal urine the concentration of calcium oxalate salt is four times higher than its solubility.' High rates of calcium and oxalate excretion and low urinary volumes increase calcium oxalate supersaturation. 
su-

pe~sa~uratienl-8
When calcium oxalate supenaturation is 7 to 11 times its solubility, the dissolved calcium oxalate can form nuclei of its solid phase (nucleation). Nuclei usually form on existing surfaces (heterogeneous nucleation); possible surfaces in the kidney include epithelial linings, cell debris, urinary casts, and other crystal^.^ Nuclei rarely form in free solution (homogeneous nucleation), and only under special condit i o n~? .~ Theoretically, any factor that increases the number of heterogeneous nuclei in tubular fluid or urine, such as epithelial injury, could lower the upper metastable limit, the supenaturation at which crystals first form. Hyperuri~osuria~which ,pronotcs&e abF mation of calcium oxalate stoncs19 and710wcrs +he metastable limit of calcium, oxalate," may. act by producing urate o r ,-uric-acid seeds that-function+as heterogeneous nuclei. Both hypercalciuria and hyperuricuria promote hematuria,I2 probably from crystalluria.
Microscopic nuclei can form objects as large as stones only by growing or aggregating into large clumps. They must also anchor themselves somehow or else be swept away in the urine. Nuclei cannot grow large enough to anchor and occlude renal tubular lumens within the five to seven minutes it takes them to pass through nephrons, but they can aggregate to such a size within a m i n~t e . '~ Urate and calcium oxalate crystals anchor to surfaces of cultured renal epithelial cell^,'^^'^ may adhere in vivo to tubular cells or urothelium, and grow at leisure to the size of a stone.
Kidmy.
-inhibit.all-phases .of--erystdlization~?@~rpP$alci?jan acidic glycoprotein of renal origin that contains the unusual amino acid y-carboxyglutamic acid, inhibits calcium oxalate .nucleation, growlhi-and-aggrcgatim."'g Tamm-Horsfall mucoprotein, made in renal thick ascending limbs, inhibits aggregation alone.m Uropontin," produced by the kidney, inhibits the growth of calcium oxalate crystals; its other effects are unknown.
Cllnical Presentation of Stones
Renal--lie-beginsisuddmIy .and, intensifies over a . period d4S=m.-3@m.minutc .into azstead y, unbearabla pain. that-causes nausea and-vamirifi:e The pain, like the stone, often passes downward from the flank along a path that curves anteriorly toward the groin. Urinary frequency and dysuria can occur as the stone reaches the ureterovesical junction. When the stone passes into the bladder or moves in the ureter to decompress the urinary system, the pain vanishes so abruptly that we have seen patients glance over their shoulders as if they were looking to see where it could have gone.
Stones may cause obstructive uropathy, especially if they are painless and therefore remain undetected for long periods. Though common and disturbing for patients, bleeding has little importance of its own. Among patients who have kidney stones, cystoscopy is performed at a rate of 13 per 100 patient-years in men and 28 per I00 patient-years in women, with rates of infection of 3 and 20 per 100 patient-years, respectively.=
Management of Stom
A recent National Institutes of Health Consensus Conference on nephrolithiasis proposed general guidelines for managing stones in the kidneys and urinary tract (Table 1 Stones thatare less thanQ.cm.bu*mo~ thandmm in diameter in the kidney--rbest-be-seated ;with extracsorporeal shock-wave=.lithotr@sy done; stones that exceed 2 an, or those that exceed 1 cm and are in the lower renal poles, may best be treated with percutaneous n e p h r o l i t h~t o m y ,~~ because the use of lithotripsy alone leaves residual stones in 35 to 54 percent of cases, whereas percutaneous nephrolithotomy succeeds in most cases. Doubled stents can be placed to 
Prevention of Recurrence
Preventing stones from recurring reduces the need for urologic intervention. Because we define new stones as those not visualized on previous radiographs that are passed, removed, disrupted, or seen on x-ray films, we read all renal x-ray films ourselves, correlate the stone counts with the clinical history, and rely heavily on information from hospital, emergencyroom, and office records. Doctors and patients may call a treatment ineffective and change or stop it if they mistake old stones for new ones.
Prevention requires a diagnosis of the cause of the stone (Table 2) , with the use of urine-and bloodchemistry measurements, and stone analysis. We-cdkct three 24hour urine.samples from outpatients.ge1-lowing their. normal -diets, each with-a-corresponding blood sample drawn &tween:il and49 am., 12.hours after-themost--reent.mcal. I n each urine and blood sample we measure concentrations of calcium, mag-*csiurn, phosphorus, uric;acid, and creahine; in one blood sample, sodium and potassium; and in the three urine samples, oxalare,citmte, pH, and -v01ume. We perform cystine screenine on all patients.
Although the Consensus Conferencez4 recommended collecting at least one blood and urine sample from all patients with recurrent stones, we use three urine samples to estimate variability. We evaluate and treat patients with a first stone, because a majority eventually have a recurrence, if left untreated." The Consensus Conferencez4 recommended that only blood measurements be made in patients with a first stone to detect primary hyperparathyroidism and decreased renal function, along with a conventional medical evaluation. The Consensus Conference rejected the idea that extracorporeal shock-wave lithotripsy can supplant medical prevention, since the former has risks and costs and since stones cause pain and time lost from work. Controlled trials that we discuss later in this review document the effectiveness of easily used medical methods of prevention.
Primary Hyperparathyroidism
Parathyroid hormone increases the synthesis of 1~~2 5 -d i h y d r o~~v i t a m i n D3 (calcitriol), which increases the intestinal absorption of calcium3'; parathyroid hormone also raises renal tubular calcium r e a b~o r p t i o n~~ as well as the rate of bone turnover.33 Jncreasedaerum: parathyroid hormone :theref~~~~'~~siAaypercalcemia and-hypercal&urid3*W that incresises the supersaturation of calcium oxalate in the urine.".36 High serum levels of the hormone lower the serum phosphorus because parathyroid hor- 
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Infection with bnert th! cxprur urruc
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Cyainuria mone reduces the reabsorption of phosphorus by the renal tubulesg2 more than calcitriol raises intestinal phosphorus absorption3'; low serum phosphorus levels increase calcitriol production.37
Diagnosis
Our patients with primary stone-forming hyperparathyroidism usually have serum calcium levels between 10.2 and 10.8 mg per deciliter (2.55 and 2.70 mmol per liter), just above our own upper limit of normal of 10.1 mg per deciliter (2.52 mmol per liter)."J5 Others38 repoit higher average values. One reason for the occasional reports of "normocalcemic primary hyperparathyr~idism"~ must be the mildness of hypercalcemia as compared with the wide conventional range of normal values (9 to 10.5 mg per deciliter [2.25 to 2.62 mmol per liter]). Some believe that the measurement of ionized calcium levels improves diagnostic accuracy.%
The differential diagnosis-of hypercalcemia in persons who form stones includes sarcoidosis*a state of calcitriol excess with very low serum parathyroid hormone levelsw and elevated serum levels of angiotensin 11-converting enzyme; familial.hypocalciurk -hyptr.-cakemia; an autosomal domiinant andqapparently-be nign disorder~f-blood chemistryconly, best diagnosed by documenting hypercalcemia in blood relatives and best left ~n t r e a t e d~'~~~; malignant--neaplasxnsS; inadvertent use of-thiazidediurdos during the evaluation; overuse of vitamin D.supplemtnts; treatment with lithium, which can cause a condition very similar to primary hyperparathyroidism4s; and numerous uncommon causes. 35 We have found that almost all patients with hypercalcemia who form stones have primary hyperparathyroidism; a rare few have sarcoid or incidental familial hypocalciuric hypercalcemia.
Treatment
Among asymptomatic patients, especially postmenopausal women, the question of whether to treat hyperparathyroidism surgically or palliate it medically engenders controversy, but tke~t&ag~eemene-about 
, , ' / r / L C c c S CrL( C -w tissue into the forearm. Clues to the presence of hypernormal or low levels of serum parathyroid hormone6' plasia are familial hyperparathyroidism and evidence and urinary cyclic AMP (CAMP). Fasting should also of multiple-endocrine-gland n e o p l a~i a .~ lower urinary calcium to the levels found in normal subjects who are fasting, but this is true only for some idiopathic Hypercalciuria ~a t i e n t s .~' '~~ -A-syndrome sf-unex-plained-.hypercalciuria, idioPak and colleagues62 have proposed the existence of pathic hypercalciuria can be dktinguished4rom p itwo subtypes-of absorptivehyperca1t5Uria. By definimary hyper~aFa&yroidi~mm~n~'y-by-~its-norma~~serupn tion, all patients with absorptive hypercalciuria have dcium..ievels. Reasonable upper limits for 24-hour normal or low levels of serum parathyroid hormone urinary calcium excretion in outpatients are 250 mg levels, fasting urinary calcium levels below 0.1 1 mg (6.2 mmol) per day in women, 300 mg .half>.of aji=patieats with -calcium oxalate stones have.. ~d~o p a t h~c hypercalc-iuna, we shall discuss ~t s pathogenesls and treatment in more detail than those of the other causes of stones.
Cause diet) i s .~~i n d i w t i v t~~~f =~~~-a~s e~t i v~~-~
Idiopathic hypercalciuria affects both sexes equally h~e r c a l c~U n a I l a n d + u~n a~= 4 & u m~&~* f 4 a and occurs in successive generations and among about t h a n : 2 0 0 -m~-~e~d a y " i s~i n d~* s~e ' B l r c h & l idie half the blood relatives of a given proband, as though prithic-hypercaltiuri~Secause a diet low in calcium inherited as an autosomal dominant I n two lowers urlnary calcium to normal levels in patients large families in which many members were affected with type 2 idiopathic hypercalciuria by definition, by idiopathic hypercalciuria, a few had evidence of subtyping can in principle guide treatment. A third renal tubular acidosis,% as though idiopathic hypertype, which is like type 1 but is associated with serum calciuria led to renal tubular acidosis. Erythrocyte calphosphorus levels of less than 2.9 mg per deciliter (0.9 cium ATPase levels may vary directly with the level of mmol per liter), appears in some reports6'; presumurinary calcium excretion in members of families with ably phosphorus supplements can best treat it, as in idiopathic hypercalciuria"; both are correlated in parthe Bedouin tribe with a similar syndr~me.'~*'~ ents and their offspring but not between parents, as if A few patients who have high serum parathyroid the ATPase levels were related to the cause of idiohormone levelsM presumably lose calcium into their pathic hypercalciuria.
urine because the renal reabsorption of calcium is Some members of a Bedouin tribe in which interreduced (renal-leak hypercalciuria), leading to secmarriage is c~mmon'~,'~ have hypercalciuria as a reondary hyperparathyroidism, parathyroid hormonesult of high serum calcitriol levels caused by renal induced activation of calcitriol production, and calciphosphate wasting. Oral phosphate supplements retriol-mediated overabsorption of calcium by the intesverse the hypercalciuria, low serum phosphorus levels, tines. Pacifici et al.= could differentiate between the and rickets. In another family, one brother and one renal and absorptive forms of idiopathic hypercalciusister among seven children of a consanguineous marria with the use of isotopic-absorption measurements, riage had Fanconi's syndrome,% with rickets, eleserum parathyroid hormone levels, and urine CAMP vated serum calcitriol levels, and hypercalciuria. A measurements, but not with the use of responses to case reports5 described five members of one family oral calcium loading alone. with hypouricemia from renal urate wasting, reduced bone mineral density, normal serum phosphorus lev- 
Effects of a LOW-&/durn Diet on
Bone Mineral Density in Idiopathic Hypercalciuria
Given the calcium wasting that occurs in many patients with idiopathic hypercalciuria in response to a low-calcium diet, one might expect reduced bone mineral density in these patients. One study66 reported a reduced mean distal-radius density among patients with renal idiopathic hy~ercalciuria and a normal density among patients with absorptive idiopathic hypercalciuria. Another study reported reduced distal-radius and radial-shaft bone mineral density among patients with absorptive idiopathic hypercalciria.^^ Among unselected patients with nephrolithia-, s i~,~ bone mineral content was reduced by 5.2 percent, whether or not idiopathic hypercalciuria was present. A recent reported normal vertebral mineral density among ~a t i e n t s with type 2 idiopathic hypercalciuria and reduced density among those with type 1 disease. Overall, the evidence supports the increased likelihood of a reduction in bone mineral content in people with stones and idiopathic hypercalciuria.
Effects of Calcitriol Excess in Nonnal People
Four normal men were given sufficient calcitriol to raise urinary excretion of calcium but not serum levels of c a l~i u m .~~~~' Calcitriol worsened the negative calcium balarice during a low-calcium diet (160 mg per day), from a net loss of 80 mg to one of 280 mg; in other words, calcitriol potentiated the loss of bone mineral. Either high serum calcitriol levels or an abnormally high tissue response to calcitriol because of an increase in the number of receptors could explain both the overabsorption of calcium characteristic of idiopathic hypercalciuria and the mobilization of bone mineral induced by a low-calcium diet. Calcitriol and its analogues can also suppress the secretion of parathyroid hormone,72 explaining the failure of serum parathyroid hormone levels to rise during a lowcalcium diet.'jl
Serum Calcitriol in Idiopathic Hypercaluuria
In groups of patients with idiopathic hypercalciuria that had not been clinically subtyped, the mean blood calcitriol levels were above n~r m a l .~' .~' -~~ This finding offers an apparent explanation for the high rates of intestinal calcium absorption and bone mineral loss that occur during a low-calcium diet. In some patients with high serum calcitriol levels, calcium loading initially suppressed serum calcitriol levels to normal; after two weeks the levels rebounded, as though escap ing from control.73 But among 21 patients with idiopathic hypercalciuria7* who had high rates of calcium absorption, only 7 had high serum calciuiol levels, and we7' found normal strum calcitriol levels in 4 of 7 patients who had high rates of calcium absorption documented by calculating total metabolic balance.
Rates of calcium transport by enterocytes that are high in relation to the effects of calcitriol or, possibly, abnormal levels of the calcitriol receptor that amplify the effects of circulating calcitriol levels could explain the occurrence of calcium hyperabsorption despite the presence of normal calcitriol levels. The pathogenesis of idiopathic hypercalciuria must indude more than simple~calcium~~verabsorption in most patients, but the role of calcitriol remains uncertain.
Effects of Thiazide Diuretics on Cakium Balance and Stone Recurrence
Thiazide-diuretics lower. urinary .caluum exaction by increasing -fractional calcium -reabsorption&y the distal n e p h r~n~~ and reducing intestinal calcium absorption.77 Chlorthalidone improves77 calcium balance in severe idiopathic hypercalciuria by lowering urinary calcium excretion more than it lowers intestinal calcium absorption. In some79*" but not alle' studies, the use of thiazide diuretics by patients who did not form stones correlates with reductions in the rates of hip fracture and higher bone mineral densities.
Thiazide diuretits---and related . ; d m g a~~t d u c e -the likdih6od.of stone formatiun. In two double-blind trials lasting three years, chlorthalidone or chlorothiazide (Table 3 ) reduced the rate of stone rec~rrence'~.'~ whether or not ~a t i e n t s met the uhxal critniafor: idio--pa&hic--hypercaiciuria,-which .suggests that reducing. urinary -calcium benefits stone disease-whatever the base~line-rate-afi calcium-exmetion. The benefits of thiazide therapy were not apparent until the second year in either study; as expected, two brief, doubleblind, placebo-controlled lasting 1 year and 18 months, respectively, found no beneficial effects of thiazide treatment. Previous prospective, open trials had shown excellent results after treatment with thiazide drugs.1m103 WelW reported recurrence rates of 13 percent among women and 6 percent among men during six years of thiazide treatment, results similar to those of the placebo-controlled trials.
Effects of a Low-Calcium Diet on Stone Recurrence
In-theory, a low-calcium diet-(400.40 W : m g daily) should be'-adzsafe treatment for p a t i e n~. w i t h type Z idiopathic hypercalciuria, but-no studies have confirmed the efficacy of dietary therapyor laid .to rest the fear-of bone-mineral-loss;~thus, long-term trials are needed. Open studies report rates of recurrence of 29 percent,85 9 percent,85 and 38 percente6; none incorporated formal control groups. A low-calcium diet--seem's less effective than thiazide diuretics and pases a-theere t i d i s k -of-Bone -niineriifdoss .*-
Sodium Cellukse Phosphate
A calcium-binding resin, sodium cellulose phosphate reduces calcium absorption when taken with meals.Iw Despite encouraging results from uncontrolled ~t u d i e s ,~. " '~ a controlled study showed that sodium cellulose phosphate reduced the risk of stone formation no better than did ingestion of fluids and alteration of the diet.87 Only one study, of two patients with idiopathic hypercalciuria, documents the effects nhc side effeEu includc implred -d uae: ~d -11, paciou* ud chs rrphmuc s y n b a . serum sickncu-like mtpm. mi., ud * u~o p a t . *~~~ of sodium cellulose phosphate on calcium balance.''' Sodium cellulose phosphate has a very limited role in treatment; we have added it to thiazide diuretics to decrease urinary calcium excretion in patients with the rare combination of intractable stone recurrence and idiopathic h~~ercalciuria. Its efficacy, like that of the low-calcium diet, has not been proved. In addition, sodium cellulose phosphate increases urinary oxalate excretion, presumably by binding calcium in the intestinal 1umcn.l"
In patients with absorptive idiopathic hypercalciuria, an oral dose of 1500 mg of neutral potassium phosphate per day in three to four divided doses lowers urinary calcium excretion as effectively as thiazide diuretics. log Two uncontrolled trials reported relapse rates of 25 percenp and 9 percent." In the only controlled trial, acid phosphate increased the frequency of stones.I1O Phosphate needs more study of efficacy and systemic side effects.
Low Urinaly Cltnte
Evidence of Low Urinary Citrate in NephroIithiasis
We have described low concentrations of urinary citrate as a common trait among patients who form stones, especially women." Urine from normal women contains an average of 59.5 mg of civate per deciliter (3.10 mmol per liter) and 10.5 mg of calcium per deciliter (2.62 mmol per liter), as compared with 43.2 and 15.7 mg per deciliter (2.25 and 3.92 mmol per liter), respectively, in normal men. The sa-based difkrence in calcium concentration reflects the higher. rate of excretion by men, who a n larger than women but produce the same urinary volume. Among patients with kidney stones, the average urinary citrate con-1148 THE NEW ENGLAND JOURNAL OF MEDICINE Oct. 15, 1992 centration is only 42.3 mg per deciliter (2.2 mmol per liter) in women and 31.9 mg per deciliter (1.66 mmol per liter) in men, whereas calcium concentrations are increased because of the high prevalence of idiopathic hypercalciuria.'Two other studies also found this'sexbased dilTeren~e,"'J~~ and others have shown that patients who form stones have low urinary citrate leve l~, "~-"~ but have not found a sex-based difference in the concentrations.
Eflects of Treatment with Citmte
Because citratejowers-calcium-oxalate supersatural tion-by binding calcium, a low citrate concentration can be a risk factor for the formation of stones and treatment with citrate should prevent stones; however, no -trials of citrate have included formal controls. In one uncontrolled study, only 12 percent of citrate-treated patients formed calcium oxalate stones over a two-year period.88 Citrate lowered the rate of stone formation in 10 of 13 patients with idiopathic hypercal~iuria"~ who continued to form stones despite treatment with thiazide diuretics. In patients with bowel disease or renal tubular acidosis, who often have low. urina~y -titrate levels because,.of metah1ic -acidosisY1!f citrate therapy seems rational, although its efficacy has not been tested. Potassium bicarbonate lowers urinary calcium concentrations and increases calcium balance; sodium bicarbonate does neither,1'8J19 so we prefer potassium alkali salts.
Renal Tubular Acldosls and Calclum Phosphate S t o m
If the kidneys ,lose some o r all of their ability-to. lower urinary pH, the-rauking higher pH increases.. the proportion-of phosphate in the divalent and trivalent forms, which combine with calcium to crystallize and raise calcium phosphate s~~e r s a t u r a t i o n . "~~'~ If a decrease in renal acid excretion lowers blood pH, acidosis lowers the urinary civate concentration. by raising proximal-tubule citrate reabsorption and also increases urinary calcium loss."' Renal tubular acidosis develops in some patients with idiopathic hypercalciuria, perhaps because of papillary calcification, so that mainly calcium phosphate stones are f~r m e d .~ Because the hypercalciuria in these patients arises not from metabolic acidosis but from idiopathic hypercalciuria, it responds to thiazide diuretics but not potassium alkali salts. Other patients inherit renal tubular acid~sis'~'; their hypercalciuria arises from metabolic acidosis rather than idiopathic hypercalciuria, and responds to potassium alkali salts.
Although patients who form calcium phosphate stones may acidify their urine normally, the majority have renal tubular a~i d 0 s i s . l~~
We measure the blood pH in these patients. If metabolic acidosis is present, along with 24-hour urinary pH values above.6.5 and hypercalciuria, we treat them with a potassium alkali salt (2 meq per kilogram daily in two to three divided doses) and monitor urinary pH, citrate, and calcium. If the hypercalciuria persists, we add a thiazide diuretic to the therapeutic regimen. In the absence of metabolic acidosis, we use thiazide diuretics to treat the hypercalciuria and potassium alkali salts to treat the low urinary citrate level. This is the same regimen we use to treat patients whose urinary calcium excretion does not fall after treatment with potassium alkali salts alone; we find no need to perform ammonium chloride-loading tests to quantify the acidification def e c t~. "~ Rather than measure blood pH, one may look for very low urinary citrate excretion (<100 mg [5.33 mmol] per day) combined with a 24-hour urinary pH above 6.5, a clue we find useful for the diagnosis of renal tubular acidosis.
Hyperoxalurb
Dietary Hyperoxaluria
Normal people excrete 20 to 40 mg (222 to 444 pmol) of oxalate daily; a reasonable upper limit of excretion is about 45 mg (500 pmol) daily' for either sex. Axsimple -dietary wcess..of -d a t e , from foods , such as spinach, rhubarb, Swiss chard, cocoa, beets, peppers, wheat germ, pecans, peanuts, okra, chocolate, and lime peel, commonly increases-arinaxyaxik lare.to-50 6 -60 mg-(556 to 667 pmol) daily. A-~Qw-calcium diet and sodium cellulose phosphate increase urinary oxalate c~c r e t i o n .~~~'~~ The treatment consists of altering the diet to avoid an excess of oxalate and making follow-up measurements of urine; no trials prove its eficacy.
Malabsorption by the small bowel from any-causqm including r e s e c t i~n , '~~~'~~ intrinsic disease,'24 and jejunoileal by pas^,'^^.'^^ exposes the colonic mucosa to detergents in the form of bile salts and fatty acids,'28 which increase its permeability to charged and uncharged molecules, includingsugars, amino acids, and oxalate.lm In vitro. colonic e~ithelium behaves as if it has a nonselective barrier and a size-and charge-selective barrier1=; ricinoleic and taurocholic acids raise permeability through the former, leaving the latter intact. An ileostomy abolishes enteric hyperoxaluria but. as does alkaline diarrhea of any cause. also lowers urinary pH and citrate concentrations and causes uric acid crystallization, which is best treated with potassium alkali salts. The hyperoxaluria from small-bowel malabsorption often exceeds 100 mg (1 11 1 pmol) daily and provokes frequent stone formationlgO and even tubulointerstitial renal disease from intrarenal calcificationS. 126.127.131-133 Treatments include reducing dietany. oxalate and fatw; oral calcium supplements (1 to 4 g of calcium as the carbonate salt in three to four divided doses with meals) that-precipitate-o x d a t c~i n --the inteshnai lamenw;-cholestyramine; .a nonabsm-bable.qcsin--that binds-fazq-.adds;-bile acids %aud:;oxda$e. (4 to 16 g daily in four divided doses with meals); oral citrate supplements; and high fluid intake. We prefer. to use all treatments, each at a low level, rather than a single one at its maximal level.
Type 1 primary hyperoxaluria, an autosomal recessive trait, results from molecular abnormalities that 
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reduce the activity of hepatic peroxisomal alanineglyoxylate aminotransferase:' thereby increasing the availability of glyoxylate, which is irreversibly converted to oxalic add. Some abnormalities cause the transfer of active alanine-glyoxylate aminotransferase to mitochondria instead of hepatic microsomcs (about one third of cases)g1; the rest reduce intrinsic alanine-glyoxylate aminotransferase activity. A rare form of hyperoxaluria results from a deficiency of D-glycerate dehydrogenase or glyoxylate reductase (type 2). Both forms cause a high level of oxalate production and corresponding urinary oxalate excretion above 135 to 270 mg (1.5 to 3 mmol) daily.9'~92*'34 Stone formation often begins in childhood; tubule interstitial nephropathy92~'35 progresses to chronic renal failure. Serum oxalate levels increase in all types of chronic renal failurelS6; exaggerated increases in primary hyperoxaluria cause calcium oxalate deposition in the heart, bones, joints, eye, and other tissues.
Pyridoxine supplements92 (2 to 200 mg daily) lower oxalate production in some patients. The rest can be treated by increasing urinary volume to 3 liters daily and adding supplemental oral citrate, thiazide diuretics for those with hypercalciuria, and possibly oral phosphate Renal transplantation requires a special protocol to avoid accelerated renal oxalosis?' Liver transplantation'" restores the missing enzyme; some patients have received this treatment.
The most compelling evidence that hyperuricosuria (the excretion of more than 800 mg [4.8 mmol] of uric acid per day in men and of more than 750 mg [4.5 mmol] per day in women) contributes to the formation of calcium oxalate comes from a ~r ospective trial that showed a reduction of stone'formation with allopurinol as compared with placebo?' Finlayson et al. '38 found no direct effect of allopurino1 on calcium oxalate crvstallization. ~e c h a n i s m s linking uric acid to calcium oxalate crystallization range from heterogeneous nucleation'39~'"' as a result of uric acid ~r~stallization'~' and reduction of naturally occuning urinary inhibitors'42-'" to salting out'45 of calcium oxalate salt by urate salts. Since an excess of purine in the diet causes hyperuricosunormal levels of dietary purine should prevent stones.
Newly Discovered inhibitor Detecta
Some patients who form stones produce TammHorsfall mucoprotein that self-aggregates and therefore becomes unable to inhibit the aggregation of calcium oxalate crystals." Some patients who form stones produce nephrocalcin that is deficient in ?carboxyglutamic acid and less able to inhibit the growth of calcium oxalate ~r~s t a l s . '~. '~ We1* and othersg have described the redbced inhibition of the m w t h . w nucleation, and aggregation of calcium oxalate in the urine of patients who form stones as compared with the urine of normal persons. Inhibitor defects may eventually be found to be the cause of some types of kidney stones.
The solubility of fully protonated uric acid in urine at a temperature of 37°C is 96 mg per litu.I4' T h e pK, (the negative logarithm of the acid ionization constant) for the first proton dissociation approximates 5.35; at that pH, half the uric acid is fully protonated, making supersaturations inevitable at normal acretion rates of 600 to 800 mg (3.6 to 4.8 mmol) per day in 1 to 1.5 liters of urine. Wehw found that the mean (2SE) pH of urine in patients who form uric acid stones was 5.520.4, as compared with 6.02 0.4 among patients who form calcium oxalate stones and 5.7 ~0 . 4 '~ among patients whose stones contain both materials; the third group makes up approximately 12 percent of our clinic population.
The stones are treated by.raisingurinaay.pH~o-6~ 6~5 -w i t h .~' t a s s i u m~l W d b s . "~~' '9*'5'*'52 Hyperuricosuria in which less than 1200 mg (7.1 mmol) of uric acid is excreted daily need cause little concern if the pH exceeds 6, but above this level treatment with all* purinol may be beneficial. Unlike calcium oxalate stones, uric acid stones readily dissolve once urinary pH rises, unless coated with calcium oxalate.
STRWITE STONES
The usual causative bacteria of struvite stones'53 include -5, Wsidla, psedmmnas species, and ent~iemsi; Zschnichia w h ' . m w m -c a u~~z~~ Patients whose clinical symptoms of stone disease are the passage of a stone tend to have idiopathic hypercalciuria and normal renal function and to ~r o d u c e both struvite and calcium oxalate stones.'" Those who produce only struvite stones present with .large stones that cause bleeding, obstruction, or infection, without stone passage; they rarely have idiopathic hypercalciuria and often have reduced renal function. Idiopathic hypercalciuria or other metabolic disorders presumably create calcium stones in the first group that later become infected. Contralateral spread is frcquent.'" Struvite stones require removal; extracorporeal shock-wave lithotripsy and percutaneous nephrolithotomy (Table 3) can be used to reduce the damage incurred by the growth and spread of these stones. Prolonged use of antibiotics in patients with stones amounts to treatment for an infected foreign body. Once patients are free of stones. thev should benefit . . from antibiotics directed against the predominant uri--nary organisms, although no controlled studies support this reasonable approach. An inhibitor of the urease enzvmeg5 that can reduce stone formation has proved of iimited use because of side effects.
Because of hereditary defects of amino acid transport, a few persons &mete in their urine excessive amounts of cystine, the disulfide of cysteine, which is soluble in urine to the level of only 24 to 48 mg per deciliter (1 to 2 mmol per liter). - The rate of cystine 1150 THE NEW ENGLAND JOURNAL OF MEDICINE Oct. 15, 1992 excretion in these patients ranges from 480 to 3600 mg (2 to 15 mmol) per day, so that a high fluid intake can prevent stones in only some. We measure urinary cystine and estimate the urinary volume needed to dissolve it; if it is within 4 liters daily, we use only high fluid intake, with attempts to avoid overnight dehydration, and increase urinary pH above 7 to increase cystine solubility; this procedure is safe unless idiopathic hypercalciuria also occurs. If increasing urine volume alone is insufficient, we begin treatment with penicillamineM (1 to 2 g daily) or t i~p r o n i n .~~ Both combine with cysteine to form a soluble salt that reduces through competition the formation of cystine.'' The ability of acetylcysteine to increase urinary cystine disqualifies it as a treatment, even though it forms a soluble cysteine di~ulfide."~ Treatment of stones that are already formed resembles that for struvite stones except that infection is unlikely to occur. The stones are hard to disrupt by extracorporeal shockwave lithotripsy, and percutaneous nephrolithotomy is often required. Like uric acid stones, they may dissolve with a high fluid intake or appropriate drugs.
